BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 21910729)

  • 41. Administration of alpha-galactosylceramide impairs the survival of dendritic cell subpopulations in vivo.
    Simkins HM; Hyde E; Farrand KJ; Ong ML; Degli-Esposti MA; Hermans IF; Ronchese F
    J Leukoc Biol; 2011 May; 89(5):753-62. PubMed ID: 21297009
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regulatory natural killer T cells protect against spontaneous and recurrent type 1 diabetes.
    Sharif S; Arreaza GA; Zucker P; Delovitch TL
    Ann N Y Acad Sci; 2002 Apr; 958():77-88. PubMed ID: 12021086
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [NK-T cell activator (α-GalCer) accelerates immune and hematological reconstitution after murine allo-bone marrow transplantation].
    Liu JH; Zhou F; Dou LP; Liu YQ; Wang JG; Bai Y; Guo BY; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1542-7. PubMed ID: 21176367
    [TBL] [Abstract][Full Text] [Related]  

  • 44. α-Galactosylceramide but not phenyl-glycolipids induced NKT cell anergy and IL-33-mediated myeloid-derived suppressor cell accumulation via upregulation of egr2/3.
    Huang JR; Tsai YC; Chang YJ; Wu JC; Hung JT; Lin KH; Wong CH; Yu AL
    J Immunol; 2014 Feb; 192(4):1972-81. PubMed ID: 24465013
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dendritic cells combined with tumor cells and α-galactosylceramide induce a potent, therapeutic and NK-cell dependent antitumor immunity in B cell lymphoma.
    Escribà-Garcia L; Alvarez-Fernández C; Tellez-Gabriel M; Sierra J; Briones J
    J Transl Med; 2017 May; 15(1):115. PubMed ID: 28549432
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Depletion of CD4+CD25+ regulatory T cells enhances natural killer T cell-mediated anti-tumour immunity in a murine mammary breast cancer model.
    Hong H; Gu Y; Zhang H; Simon AK; Chen X; Wu C; Xu XN; Jiang S
    Clin Exp Immunol; 2010 Jan; 159(1):93-9. PubMed ID: 19817769
    [TBL] [Abstract][Full Text] [Related]  

  • 47. α-Galactosylceramide-activated murine NK1.1(+) invariant-NKT cells in the myometrium induce miscarriages in mice.
    Ichikawa T; Negishi Y; Shimizu M; Takeshita T; Takahashi H
    Eur J Immunol; 2016 Aug; 46(8):1867-77. PubMed ID: 27198610
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Solubilization of α-galactosylceramide in aqueous medium: Impact on Natural Killer T cell activation and antitumor responses.
    Macho-Fernandez E; Chekkat N; Ehret C; Thomann JS; De Giorgi M; Spanedda MV; Bourel-Bonnet L; Betbeder D; Heurtault B; Faveeuw C; Fournel S; Frisch B; Trottein F
    Int J Pharm; 2017 Sep; 530(1-2):354-363. PubMed ID: 28743554
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Avidity of CD1d-ligand-receptor ternary complex contributes to T-helper 1 (Th1) polarization and anticancer efficacy.
    Wu TN; Lin KH; Chang YJ; Huang JR; Cheng JY; Yu AL; Wong CH
    Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17275-80. PubMed ID: 21987790
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activated iNKT cells promote memory CD8+ T cell differentiation during viral infection.
    Reilly EC; Thompson EA; Aspeslagh S; Wands JR; Elewaut D; Brossay L
    PLoS One; 2012; 7(5):e37991. PubMed ID: 22649570
    [TBL] [Abstract][Full Text] [Related]  

  • 51. T cell populations in the pancreatic lymph node naturally and consistently expand and contract in NOD mice as disease progresses.
    Marrero I; Vong A; Dai Y; Davies JD
    Mol Immunol; 2012 Aug; 52(1):9-18. PubMed ID: 22580347
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Glycolipid alpha-C-galactosylceramide is a distinct inducer of dendritic cell function during innate and adaptive immune responses of mice.
    Fujii S; Shimizu K; Hemmi H; Fukui M; Bonito AJ; Chen G; Franck RW; Tsuji M; Steinman RM
    Proc Natl Acad Sci U S A; 2006 Jul; 103(30):11252-7. PubMed ID: 16844772
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis and biological activities of amino acids functionalized α-GalCer analogues.
    Ma W; Bi J; Zhao C; Zhang Z; Liu T; Zhang G
    Bioorg Med Chem; 2020 Jan; 28(1):115141. PubMed ID: 31786009
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structure-Function Implications of the Ability of Monoclonal Antibodies Against α-Galactosylceramide-CD1d Complex to Recognize β-Mannosylceramide Presentation by CD1d.
    Clark K; Yau J; Bloom A; Wang J; Venzon DJ; Suzuki M; Pasquet L; Compton BJ; Cardell SL; Porcelli SA; Painter GF; Zajonc DM; Berzofsky JA; Terabe M
    Front Immunol; 2019; 10():2355. PubMed ID: 31649670
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Decreased expressions of CD1d molecule on liver dendritic cells in subcutaneous tumor bearing mice.
    Tatsumi T; Takehara T; Yamaguchi S; Sasakawa A; Yamamoto M; Fujita Y; Miyagi T; Ohkawa K; Hayashi N
    J Hepatol; 2008 Nov; 49(5):779-86. PubMed ID: 18760855
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phenotypical and functional alterations during the expansion phase of invariant Valpha14 natural killer T (Valpha14i NKT) cells in mice primed with alpha-galactosylceramide.
    Ikarashi Y; Iizuka A; Koshidaka Y; Heike Y; Takaue Y; Yoshida M; Kronenberg M; Wakasugi H
    Immunology; 2005 Sep; 116(1):30-7. PubMed ID: 16108815
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Potent anti-tumor responses to immunization with dendritic cells loaded with tumor tissue and an NKT cell ligand.
    Petersen TR; Sika-Paotonu D; Knight DA; Dickgreber N; Farrand KJ; Ronchese F; Hermans IF
    Immunol Cell Biol; 2010 Jul; 88(5):596-604. PubMed ID: 20142835
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Activating Fc gamma receptors participate in the development of autoimmune diabetes in NOD mice.
    Inoue Y; Kaifu T; Sugahara-Tobinai A; Nakamura A; Miyazaki J; Takai T
    J Immunol; 2007 Jul; 179(2):764-74. PubMed ID: 17617565
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dendritic cell internalization of α-galactosylceramide from CD8 T cells induces potent antitumor CD8 T-cell responses.
    Choi DH; Kim KS; Yang SH; Chung DH; Song B; Sprent J; Cho JH; Sung YC
    Cancer Res; 2011 Dec; 71(24):7442-51. PubMed ID: 22028323
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lipo-Based Vaccines as an Approach to Target Dendritic Cells for Induction of T- and iNKT Cell Responses.
    Stolk DA; de Haas A; Vree J; Duinkerken S; Lübbers J; van de Ven R; Ambrosini M; Kalay H; Bruijns S; van der Vliet HJ; de Gruijl TD; van Kooyk Y
    Front Immunol; 2020; 11():990. PubMed ID: 32536918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.